VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares rose 4.8% during mid-day trading on Tuesday . The stock traded as high as C$0.22 and last traded at C$0.22. Approximately 30,500 shares were traded during mid-day trading, a decline of 69% from the average daily volume of 98,865 shares. The stock had previously closed at C$0.21.
VentriPoint Diagnostics Price Performance
The stock has a market capitalization of C$32.93 million, a P/E ratio of -7.17 and a beta of 0.39. The company has a current ratio of 2.06, a quick ratio of 6.67 and a debt-to-equity ratio of 32.61. The stock’s 50 day simple moving average is C$0.25 and its 200 day simple moving average is C$0.24.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- The How and Why of Investing in Biotech Stocks
- Comprehensive PepsiCo Stock Analysis
- What does consumer price index measure?
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Bear Market Funds to Watch This Year
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
